TERS
LIVE

Serial Number

87391827

Owner

JPT Peptide Technologies GmbH

Attorney

Monica Riva Talley

First Use Date

Jun 16, 2017

Filing Date

Mar 30, 2017

Add to watchlist:

No watchlists yet
View on USPTO

TERS Trademark

Serial Number: 87391827 • Registration: 5991518

TERS is a trademark filed by JPT Peptide Technologies GmbH on March 30, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

JPT Peptide Technologies GmbH (9 trademarks)

Volmerstraße 5

Entity Type: 16

Trademark Details

Filing Date

March 30, 2017

Registration Date

February 18, 2020

First Use Anywhere

June 16, 2017

First Use in Commerce

August 14, 2017

Published for Opposition

February 5, 2019

Goods & Services

(Based on 44(e)) (Based on Use in Commerce) Nucleic acids, in particular RNA for use as reference standards in science and industry; control agents, namely, certified samples of nucleic acids; TCR-engineered reference samples; reagents for use as transfection, control and standardization agents

(Based on 44(e)) (Based on Use in Commerce) Preparations and diagnostic test kits comprising nucleic acids, solvents, and printed instructions for clinical or medical laboratory use, in particular for use in analysis of gene expression, in particular analysis of engineered blood cells and for use in determining the progression of diseases, and for use in determining drug and therapeutic responses; diagnostic laboratory reagents for use as transfection, control and standardization reagents

(Based on 44(e)) Scientific and industrial research and development in the field of biochemistry and immunology; research and development of reference materials, in particular nucleic acids for use as reference standards in scientific and industrial laboratories; Clinical or medical laboratory services; gene expression and blood cell testing to determine immune response, detection of diseases, progression of diseases, and response to treatments; cultivation and purification of cells, in particular of body cells and cells of the immune system of mammals including human cells

(Based on 44(e)) Clinical and medical diagnostic services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 22, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 22, 2026 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 22, 2026 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 22, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 22, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 22, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 22, 2026 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 18, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 16, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 15, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 9, 2020 SUPC
USE AMENDMENT FILED
Jan 2, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 2, 2020 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 18, 2019 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 18, 2019 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 3, 2019 EXRA
SOU EXTENSION 1 GRANTED
Oct 1, 2019 EX1G
SOU EXTENSION 1 FILED
Oct 1, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 1, 2019 EEXT
TEAS DELETE 1(B) BASIS RECEIVED
Sep 27, 2019 D1BR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2019 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 2, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 5, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 5, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 16, 2019 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Dec 28, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 21, 2018 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 11, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 12, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 12, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 12, 2018 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 12, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 12, 2017 GNSL
SUSPENSION LETTER WRITTEN
Dec 12, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2017 CRFA
ASSIGNED TO LIE
Dec 5, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 27, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2017 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 5, 2017 NWOS
NEW APPLICATION ENTERED
Apr 3, 2017 NWAP